Introduction
For effective and safe in vivo gene transfer, the development of targeted gene delivery systems is a promising approach. To achieve targeted gene delivery to hepatocytes, galactose has been shown to be a promising targeting ligand to hepatocytes (liver parenchymal cells) because these cells possess a large number of asialoglycoprotein receptors that recognize the galactose units on the glycoproteins or synthetic galactosylated carriers (Kawakami et al., 2002) . Recently, we have developed several types of macromolecular and particulate gene carriers for hepatocyte-selective gene transfection in vivo (Kawakami et al., 2000; Morimoto et al., 2003; Fumoto et al. 2004 ). These include galactosylated cationic liposomes containing cholesten-5-yloxy-N-(4-((1-imino-2-D-thiogalactosyl-ethyl)amino)butyl) formamide (Gal-C4-Chol) that can be efficiently recognized by asialoglycoprotein receptors in hepatocytes in vivo (Kawakami et al., 2000; Fumoto et al. 2004 ). However, a number of possible barriers are associated with in vivo gene delivery (Yang and Huang, 1997; Li et al., 1999; Sakurai et al., 2001a; Fumoto et al., 2003a) . Detailed information about these barriers is needed to allow the rational design of effective gene carriers.
When galactosylated liposome/pDNA complex (lipoplex) was injected into the portal vein of mice, most of it was taken up by the liver (Kawakami et al., 2000) . However, the level of in vivo gene expression was not as high as that expected from the in vitro results. Thus, there must be several barriers associated intrinsically with in vivo situations, such as convective blood flow in the liver, passage through the sinusoids, and tissue interactions. To elucidate these barrier processes, we investigated the hepatic disposition profiles of galactosylated lipoplex in rat liver perfusion experiments (Fumoto et al., 2003a) , which allowed us to determine the uptake characteristics of a range of substances under different 1997). A charge ratio of unity was obtained with 2.52 µg total lipid/µg pDNA for galactosylated liposomes in this study. As far as the charge ratio was concerned, we selected a charge ratio of +2.3 for all experiments to obtain the most effective transfection activity for receptor-mediated gene transfer (Kawakami et al., 2000; Kawakami et al. 2004) and to prevent any effect of free liposomes (Eastman et al., 1997; Sakurai et al., 2001a) . The particle size and zeta potential of the galactosylated lipoplex were measured, using a dynamic light scattering spectrophotometer (LS-900, Otsuka Electronics, Osaka, Japan) and a laser electrophoresis zeta-potential analyzer (LEZA-500T, Otsuka Electronics), respectively.
Preparation of serum and whole blood. Mouse or rat serum was prepared by the method of Sakurai et al. (2001a) . Briefly, mouse serum was isolated from fresh whole blood obtained from ICR mice. Blood was collected from the vena cava under anesthesia without heparin treatment and allowed to stand for 3 h at 37°C and then overnight at 4°C. Serum was collected after centrifugation. Inactivated serum was prepared by heating serum for 30 min at 56ºC. Whole blood was collected in a heparinized syringe from ICR mice. An erythrocyte suspension was prepared as described in a previous report (Senior et al., 1991) , by washing whole blood three times with phosphate buffered saline (PBS, pH7.4).
In vivo transfection experiments. Prior to intraportal injection, galactosylated lipoplex was incubated with blood components for 5 min at 37ºC. Mice were anesthetized by intraperitoneal administration of pentobarbital sodium (50 mg/kg). An incision was made in the abdomen, and the portal vein was exposed. The lipoplex pre-incubated with blood components was injected into the portal vein at a volume of 15 ml/kg, and the abdomen was closed with wound clips. Liver samples were taken 6 h after injection and each sample was homogenized with lysis buffer (0.1 M Tris/HCl containing 0.05% Triton X-100 and 2 mM EDTA (pH 7.8)). After three cycles of freezing and thawing, the homogenates were centrifuged at 10,000 g for 10 min at 4 ºC. Twenty microliters of each supernatant was mixed with 100 µl luciferase assay solution (Picagene, Toyo Ink Mfg. Co., Tokyo, Japan) and the light produced was immediately measured using a luminometer (Lumat LB 9507, Berthold Technologies, GmbH & Co., Bad Wildbad, Germany). The protein content of the samples was determined using a protein quantification kit (Dojindo Molecular Technologies Inc., Gaithersburg, MD, USA). For evaluation of the intrahepatic localization of gene expression, the luciferase activities in the liver parenchymal (PC) and non-parenchymal cells (NPC) were independently determined after centrifugal separation of PC and NPC in collagenase-digested liver as previously described (Kawakami et al., 2000) . In the inhibition experiments involving hepatic transfection, mice received intravenous injections of 20 mg/kg Gal-BSA 1 min prior to the intraportal injection of the lipoplex.
In vivo distribution study. [ 32 P] labeled galactosylated lipoplex pre-incubated with blood components was injected into the portal vein of mice at a volume of 15 ml/kg. At each collection time point, blood was collected from the vena cava and mice were killed at the end of the experiment. The liver, kidneys, spleen, heart, and lungs were removed, washed with saline, blotted dry, and weighed. Ten microliters blood and a small amount of each tissue were digested with 0.7 ml Soluene-350 by incubating overnight at 45 °C. Following digestion, 0.2 ml isopropanol, 0.2 ml 30 % hydroperoxide, 0.1 ml 5 M HCl, and 5.0 ml Clear-Sol I were added. The samples were stored overnight and the radioactivity was J P E T # 8 9 5 1 6 1 0 measured in a scintillation counter (LSA-500, Beckman, Tokyo, Japan).
Calculation of organ uptake clearance. Tissue distribution data were evaluated using organ uptake clearances as reported previously (Takakura et al., 1987) . Briefly, the tissue uptake rate can be described by the following equation 
where AUC (0~t) represents the area under the blood concentration time curve from time 0 to t. The CL uptake value can be obtained from the initial slope of a plot of X t vs AUC (0~t) .
Liver perfusion experiments and pharmacokinetic analysis. In situ liver perfusion studies were carried out as reported previously (Nishida et al. 1989; Fumoto et al., 2003a) . Briefly, the portal vein was catheterized with a polyether nylon catheter (SURFLO ® I.V. Catheter, 16 G´2", Terumo Co., Tokyo, Japan) and immediately perfused with Krebs-Ringer bicarbonate buffer supplemented with 10 mM glucose (oxygenated with 95% O 2 -5% CO 2 , adjusted to pH 7.4 at 37 °C). The perfusate did not contain serum proteins and blood cells. The perfusate was circulated using a peristaltic pump (SJ-1211, ATTO Co., Tokyo, Japan) at a flow rate of 13 ml/min. After a stabilization period of 25 min, [
labeled galactosylated lipoplex pre-incubated with rat serum or whole blood (30 µg pDNA/300 µl) was 1 1 administered via the portal vein using a six-position rotary valve injector (Type 50 Teflon rotary valves, Rheodyne Inc., Cotati, CA, USA). After addition of 5 ml Clear-Sol I, the radioactivity of the effluent perfusate was measured in a scintillation counter (LSA-500, Beckman Coulter, Inc., CA, USA).
The outflow patterns were analyzed by statistical moment analysis. Briefly, the area under the curve (AUC) and mean residence time (MRT) were calculated as follows:
where t is the time and C is the concentration of [ 32 P] labeled galactosylated lipoplex. The moments can be calculated by numerical integration using a linear trapezoidal formula and extrapolation to infinite time based on a monoexponential equation (Yamaoka et al., 1978) . The t values were corrected for the lag-time of the catheter. The recovery ratio (F) and extraction ratio (E) were derived from F = AUC · Q (flow rate) and E = 1 -F, respectively.
The outflow patterns were also analyzed based on a two-compartment dispersion model, where sinusoidal and binding compartments were considered. The mass balance equations involving the axial dispersion in the sinusoidal space are as follows:
where C S (t, z) and C B (t, z) are the concentrations of drug in the sinusoidal space and binding compartment, respectively; D is the dispersion coefficient; ε is the volume ratio of the binding compartment to the sinusoidal space in the liver; k 12 and k 21 are the forward and backward partition rate constants between the sinusoidal space and binding compartment; k int is the first-order internalization rate 
where ( ) Each parameter (D C , k 12 , k 21 , k int, and V S ) was calculated by curve fitting of the Laplace-transformed equation to the experimental venous outflow pattern using a nonlinear least squares program with a fast inverse Laplace transform algorithm MULTI (FILT) (Yano et al., 1989) . The damping Gauss Newton method with no constraint was used for curve fitting with the MULTI algorithm.
Here, f I (t) was assumed to be a delta function, since the lipoplexes were rapidly injected using a six-rotary valve injector.
For evaluation of the intrahepatic localization of the amounts taken up, thirty minutes after injection of [ 32 P] labeled galactosylated lipoplex into the isolated perfused liver, the radioactivities in the liver parenchymal (PC) and non-parenchymal cells (NPC) were separately determined after centrifugal
separation of PC and NPC in collagenase-digested liver as previously described (Fumoto et al., 2003a) . Agarose gel electrophoresis. The pDNA stability of the galactosylated lipoplex in blood was determined by agarose gel electrophoresis. The galactosylated lipoplex was pre-incubated with blood components at 37 ºC. After incubation, pDNA was extracted from the mixture by phase separation using phenol/chloroform/isoamyl alcohol (25: 24: 1), followed by precipitation with ethanol. Precipitated
Results

Effect of blood components on the physicochemical characteristics of galactosylated lipoplex.
To investigate the effect of serum protein on the physicochemical characteristics of galactosylated lipoplex, the particle size, and zeta potential were measured after exposure to mouse serum because these parameters affect the hepatic disposition of galactosylated lipoplex (Fumoto et al., 2003a) . Mixing with serum (30% (v/v)) significantly enlarged the particle size of the lipoplex (TABLE   1 ). The zeta potential of the galactosylated lipoplex was significantly reduced by mixing with serum and the charge became negative, suggesting that negatively charged serum proteins covered much of the galactosylated lipoplex surface. These results are consistent with our previous report about the conventional lipoplex (Sakurai et al., 2001a) .
After mixing galactosylated lipoplex with erythrocyte suspension, hemagglutination was 
Transfection activities of galactosylated lipoplex pre-incubated with blood components.
To study the effect of blood components on in vivo transfection activity, galactosylated lipoplex was pre-incubated with serum or whole blood prior to administration and the transfection activities in the liver were evaluated 6 h after intraportal injection to mice. When the galactosylated lipoplex was 1 6
pre-incubated with serum, the hepatic transfection activities were enhanced about 20-to 70-fold (Fig.   1A ). However, incubation with whole blood (30% (v/v)) reduced the transfection activity in the liver by 97% (Fig. 1B) . These results show that the interaction with blood cells markedly inhibits the hepatic transfection activity of galactosylated lipoplex. In addition, higher concentration of blood components exhibited more marked effect on transfection activity. In in vivo condition, blood volume is larger than the volume of the lipoplex solution. Thus, the result of 30% blood or serum would be more close to in vivo condition than the result of 15% blood components. Therefore, we applied 30% blood components as the experimental condition for further studies.
In vivo distribution of galactosylated lipoplex pre-incubated with serum.
To investigate why the transfection activity of galactosylated lipoplex was enhanced by incubation with serum, the biodistribution of galactosylated lipoplex pre-incubated with serum was evaluated using [ 32 P] labeled galactosylated lipoplex (Fig. 2) . However, similar distribution patterns in the liver and other organs were observed with or without incubation with serum and, accordingly, this result did not correlate with the enhanced hepatic transfection activity of the galactosylated lipoplex pre-incubated with serum.
In situ hepatic disposition of galactosylated lipoplex pre-incubated with blood components.
We performed pharmacokinetic analyses using a single-pass rat liver perfusion experiment that allowed us to evaluate the local disposition of the carrier systems. The venous outflow profile of the complexes (Fig. 3) following a bolus input into the isolated perfused liver was analyzed by a two-compartment dispersion model to quantitatively evaluate the difference in each kinetic process.
This article has not been copyedited and formatted. The final version may differ from this version. pre-incubated with rat blood components. Incubation with serum significantly reduced the extraction ratio of galactosylated lipoplex while the effect of incubation with rat whole blood on the extraction ratio was minor. However, the mean residence time (MRT) of the galactosylated lipoplex in the liver was significantly reduced following incubation with serum. To clarify each kinetic process in perfused liver, the binding and internalization processes were evaluated by a two-compartment dispersion model. As shown in Fig. 3 , the simulation curves using the model were in good agreement with the observed data.
The validation of two-compartment dispersion model was discussed in our previous report (Fumoto et al., 2003a) . The association rate (k 12 ) of the galactosylated lipoplex was reduced by half following incubation with serum (TABLE 3) . However, the dissociation rate (k 21 ) was reduced by 80% by serum;
as a consequence, the tissue binding affinity (k 12 /k 21 ) was 2.6-fold higher than that without pre-incubation.
On the other hand, incubation with whole blood significantly increased the dissociation rate while maintaining the high association rate; as a result the tissue binding affinity (k 12 /k 21 ) was reduced by 60%
following incubation with whole blood.
Assessment of galactosylated lipoplex stability in blood.
To evaluate the differences in galactosylated lipoplex stability with or without incubation with serum, we performed fluorescent resonance energy transfer (FRET) analysis. Galactosylated lipoplex was labeled with both fluorescein-labeled pDNA (Fl-pDNA, green fluorescence) and rhodamine-labeled lipid (Rh-lipid, red fluorescence). A mixture of galactosylated lipoplex and mouse blood components was centrifuged after 5 min incubation and, subsequently, the erythrocyte compartment and supernatant were examined using confocal laser scanning microscopy and spectrofluorophotometry, respectively.
This article has not been copyedited and formatted. The final version may differ from this version. Following incubation with whole blood, the signal of the erythrocyte compartment was found to be red (Fig. 4A ) while the energy transfer from Fl-pDNA to Rh-lipid in the supernatant was reduced (Fig. 4C) ,
suggesting that the pDNA and lipids in the lipoplex had dissociated. On the contrary, pre-incubation with serum before incubation with erythrocyte suspension did not induce such dissociation of pDNA and lipids in the lipoplex (Fig. 4B, C) . The dissociation of pDNA from cationic liposomes might cause degradation by serum nuclease and, therefore, agarose gel electrophoresis was performed to analyze the degradation of pDNA (Fig. 5) . Pre-incubation with serum before mixing with erythrocyte suspension markedly inhibited pDNA degradation, indicating that pre-incubation with serum stabilized the lipoplex.
Hepatic cellular localization of galactosylated lipoplex with or without incubation with serum.
The hepatic cellular localization of [ 32 P] labeled galactosylated lipoplex was investigated following bolus injection into perfused rat liver (Fig. 6A) . When the radioactivity associated with PC
and NPC per unit cell number was measured, the PC/NPC ratio for the galactosylated lipoplex with pre-exposure to serum was 1.0, which was comparable with the galactosylated lipoplex without pre-exposure to serum (PC/NPC ratio: 1.1). As for the hepatic cellular localization of transfection activity in mice, both gene expression in PC and NPC of galactosylated lipoplex with pre-incubation with serum were one order of magnitude higher than the values for the lipoplex without pre-incubation (Fig. 6B ).
Inhibition experiment of hepatic transfection activity of galactosylated lipoplex.
To confirm whether galactosylated lipoplex exposed to serum is recognized by asialoglycoprotein receptors on hepatocytes, we performed an inhibition experiment involving pre-dosing with Gal-BSA (Fig. 7A ). The hepatic transfection activity was significantly inhibited by Gal-BSA, suggesting that the serum-protein bound galactosylated lipoplex is recognized by asialoglycoprotein receptors.
Effect of inactivation of serum on transfection activity and biodistribution of galactosylated lipoplex.
Opsonin activity in serum might affect the in vivo distribution and subsequent transfection activity of the lipoplex. To confirm the effect of opsonin activity in serum, serum was inactivated by heating prior to incubation with the lipoplex. Figure 7B shows the effect of inactivation of mouse serum on the hepatic transfection activity of the lipoplex 6 h after intraportal injection to mice. About 85% of the hepatic transfection activity of the galactosylated lipoplex was attenuated by inactivation of serum, suggesting that some factor, such as complement components, is involved in the hepatic transfection activity of the galactosylated lipoplex.
To investigate the inactivation of serum further, we evaluated the in vivo distribution after intraportal injection of [ 32 P] labeled galactosylated lipoplex. Figure 8 shows the blood concentration and tissue accumulation (liver and lung) at the indicated time points. Inactivation with serum significantly reduced the accumulation not only in the liver but also in the lung while an increased blood concentration was observed at the early time points. To estimate the effect of pre-incubation with inactivated serum on organ uptake of galactosylated lipoplex, we calculated organ uptake clearance (TABLE 4) . The hepatic uptake clearance was the highest of all the tissues. The hepatic uptake clearance was markedly reduced by incubation with inactivated serum. These differences in distribution caused by inactivation of serum will be involved in the difference seen in the hepatic transfection activity of galactosylated lipoplex
Discussion
A number of possible barriers for targeted gene delivery to hepatocytes are thought to be limiting factors for in vivo transfection including : i) non-specific interactions with erythrocytes, serum, and non-target cells, ii) aggregation of lipoplex, and iii) penetration of endothelial cells. It is necessary to discover the fate of the gene carrier in order to improve and/or develop an effective gene carrier system.
In the present study, we evaluated the effect of blood components (serum and whole blood) on asialoglycoprotein receptor-mediated in vivo gene transfer using galactosylated lipoplex. Pre-incubation with serum greatly enhanced the hepatic transfection activity of the lipoplex while pre-incubation with whole blood reduced it (Fig. 1) ; this indicates that interaction with blood components plays a crucial role in in vivo gene transfer.
Initially, we evaluated the effect of the interaction between galactosylated lipoplex and blood components on the basic physicochemical properties. Since particle size is an important factor that determines the delivery efficiency of various particulates to liver parenchymal cells (Rahman et al., 1982; Ogawara et al. 1999 ), we measured the change in particle size of the lipoplex produced by exposure to serum. As we expected, exposure of the lipoplex to serum increased the particle size (TABLE 1) .
However, the particle size of the galactosylated lipoplex following exposure to serum was comparable with the size of the fenestrae (100 -200 nm) in the liver sinusoidal endothelium (Wisse, 1970; Wisse et al., 1985; Gatmaitan et al., 1996) . Indeed, the intrahepatic distribution (PC/NPC ratio) of galactosylated lipoplex following pre-exposure to serum was similar to that of galactosylated lipoplex without pre-exposure to serum (Fig. 6A) . It was also demonstrated that the transfection activity of galactosylated lipoplex following pre-exposure to serum was equally enhanced in both PC and NPC; as a consequence the PC/NPC ratio of the transfection activity had a similar value (Fig. 6B ).
This article has not been copyedited and formatted. The final version may differ from this version. The reduced zeta potential following incubation with serum (TABLE 1) suggests that the surface of the galactosylated lipoplex is extensively covered by serum protein since most serum proteins have negative charges. However, a reduced surface charge is expected to reduce the liver accumulation.
In fact, the in situ liver perfusion experiments showed that incubation with serum reduced the extraction ratio (TABLE 2) ; however, the extraction ratio (65% of the dose) was high in absolute terms despite a single passage through the perfused liver. Furthermore, two-compartment dispersion model analysis demonstrated that incubation with serum reduced not only the association rate but also the dissociation rate; consequently, the tissue binding affinity of galactosylated lipoplex pre-incubated with serum was increased (TABLE 3) . These results indicate that pre-incubation with serum reduces the initial amount of lipoplex bound to tissue although the binding of retained lipoplex to tissue is stronger than that in the case of no incubation. As shown in Fig. 7A , the hepatic transfection activity of galactosylated lipoplex pre-incubated with serum was significantly inhibited by pre-dosing with Gal-BSA, suggesting that asialoglycoprotein receptor-mediated endocytosis markedly contributes to the high tissue binding affinity.
In contrast, incubation with whole blood did not reduce the association rate but increased the dissociation rate in the liver perfusion experiments (TABLE 3) . Under in vivo conditions, dissociation by blood cell would be more marked than in perfused liver due to the abundance of blood cells in the continuous blood flow. This analysis might explain why the liver accumulation of lipoplex without incubation after intraportal injection (Fig. 2) was relatively lower than the extraction ratio in the liver perfusion experiment (TABLE 2) . As a result, the liver accumulation of the lipoplex, with or without incubation with serum, exhibited a similar profile.
Next, we assessed the stability of the galactosylated lipoplex in blood. It is known that mixing 1996; Sakurai et al., 2000) . Blood cells have a negative surface charge and, so, they might induce dissociation of pDNA from the galactosylated lipoplex. After incubation with whole blood, dissociation of pDNA from the galactosylated lipoplex was observed (Fig. 4A, C) . On the contrary, incubation with serum inhibited such dissociation of pDNA from the galactosylated lipoplex (Fig. 4B, C) . Also, the stability of pDNA in the galactosylated lipoplex was improved by pre-incubation with serum (Fig. 5) . It has been reported that prolonged incubation with serum also induces pDNA dissociation and degradation (Li et al., 1999) . Inactivation of serum prior to incubation with galactosylated lipoplex significantly reduced both liver accumulation (Fig. 8 ) and hepatic transfection activity (Fig. 7) . It is known that the opsonin activity in serum affects the disposition of liposomes (Chonn et al. 1992; Patel, 1992) , suggesting that the disposition of galactosylated lipoplex would also be affected by opsonization. The complement component C1q, factor B and fibronectin, are heat-labile (McManus and Nakane, 1980; Hamuro et al., 1978; Rivedal, 1982) ; thus, both classical and alternative pathways of complement are no longer able to work after inactivation of serum; consequently the uptake via recognition of these factors bound to the galactosylated lipoplex would be expected to fall. In fact, the liver and lung accumulation of galactosylated lipoplex with inactivated serum was significantly reduced (Fig. 8, TABLE 4 It is known that lipoplex initiates inflammatory cytokine production via pDNA containing the unmethylated CpG motif (McLachlan et al., 2000) . When the galactosylated lipoplex was pre-incubated with serum, there was no significant change in the serum INF-γ level; therefore, incubation with serum may be a useful method for enhancing transfection activity without increasing the inflammatory response.
On the contrary, incubation with both whole blood and inactivated serum significantly reduced the serum INF-γ level. Although the mechanism is unclear, this information may useful for development of safe gene carrier with less inflammatory response.
In summary, we have shown that the interaction with blood components plays crucial role in in vivo gene transfer. While incubation of galactosylated lipoplex with whole blood reduced the hepatic transfection activity, incubation of the lipoplex with serum enhanced it. The stability of pDNA in blood rather than its in vivo distribution partially explains this difference. In contrast, inactivation with serum reduced the hepatic transfection activity, suggesting that other factor(s) in serum are involved in the hepatic transfection activity of galactosylated lipoplex. Hence, the information in this study will be valuable for the future use, design, and development of galactosylated lipoplex for in vivo asialoglycoprotein receptor-mediated gene transfer. 1 Fig. 1 . Effect of pre-incubation with serum (A) or whole blood (B) on the hepatic transfection activity of galactosylated lipoplex after intraportal injection in mice. pDNA (30 µg) was complexed with galactosylated liposomes at a charge ratio of +2.3. Five minutes prior to injection, the lipoplexes were mixed with serum or whole blood at the indicated volume ratio. Luciferase activity was determined 6 h post-injection of the lipoplex. Each value represents the mean + S.D. of at least three experiments.
Legends for Figures
Statistical comparisons with the control group were performed by Steel's test (*: P < 0.05, **: P < 0.01). Statistical comparisons with control group were performed by Dunnett's test (*: P < 0.05, **: P < 0.01). 
